We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
DXRX.LSE

Price
112.50
Stock movement up
+- (%)
Company name
Diaceutics PLC
Exchange
(LSE
,
Currency
GBX
)
Sector
Healthcare >
Health Information Services
Market cap
9.50B
Ent value
9.49B
Price/Sales
263.82
Price/Book
245.29
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
7867.13
PEG
-
EPS growth
-
1 year return
8.17%
3 year return
0.30%
5 year return
-3.22%
10 year return
-
Last updated: 2025-04-12

DIVIDENDS

DXRX.LSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF2783.44
Price to FCF-
Price to EBITDA44404.91
EV to EBITDA44357.88

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales263.82
Price to Book245.29
EV to Sales263.54

FINANCIALS

Per share

Per share data
Current share count84.47M
EPS (TTM)-0.05
FCF per share (TTM)-0.01

Income statement

Income statement data
Revenue (TTM)36.02M
Gross profit (TTM)26.55M
Operating income (TTM)-6.62M
Net income (TTM)-4.33M
EPS (TTM)-0.05
EPS (1y forward)0.01

Margins

Margins data
Gross margin (TTM)73.70%
Operating margin (TTM)-18.37%
Profit margin (TTM)-12.02%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash16.75M
Net receivables9.68M
Total current assets27.23M
Goodwill0.00
Intangible assets14.52M
Property, plant and equipment0.00
Total assets45.43M
Accounts payable610.00K
Short/Current long term debt150.00K
Total current liabilities5.61M
Total liabilities6.69M
Shareholder's equity38.74M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)3.41M
Capital expenditures (TTM)3.10M
Free cash flow (TTM)-1.15M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-11.18%
Return on Assets-9.53%
Return on Invested Capital-11.13%
Cash Return on Invested Capital-2.96%

STOCK INFORMATION

Stock chart

Stock price data
Open112.50
Daily high113.75
Daily low110.00
Daily Volume41K
All-time high187.50
1y analyst estimate175.40
Beta0.60
EPS (TTM)-0.05
Dividend per share-
Ex-div date-
Next earnings date19 May 2025

Downside potential

Downside potential data
DXRX.LSES&P500
Current price drop from All-time high-40.00%-12.89%
Highest price drop-60.27%-56.47%
Date of highest drop29 Nov 20229 Mar 2009
Avg drop from high-33.74%-11.07%
Avg time to new high70 days12 days
Max time to new high1188 days1805 days
COMPANY DETAILS
DXRX.LSE (Diaceutics PLC) company logo
Marketcap
9.50B
Marketcap category
Mid-cap
Description
Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. The company offers DXRX, a diagnostic commercialisation platform for precision medicine that integrates multiple pipelines of diagnostic testing data from network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using patient level data to determine testing rates, methodology, and the physician to lab relationship; DXRX Lab Mapping that offers insights into labs currently testing patients diagnosed with a specific disease or biomarker; and DXRX Disease Testing Rate Tracker, which delivers biomarker testing rate reports. In addition, the company offers professional services, such as market landscape, implementation, and consulting services. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
Employees
184
Website
https://www.diaceutics.com
Investor relations
-
SEC filings
DXRX.LSE SEC filings
CEO
Country
UK
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved